Table 1 Summary of five cost analysis studies
From: Systematic review of cost and cost-effectiveness of different TB-screening strategies
Study period | Country | Study population | Outcome | Strategies | Results | |
|---|---|---|---|---|---|---|
Wrighton-Smith et al. [15] | 1 year | Switzerland | 1000 contacts | Direct cost | TST-only T-SPOT.TB-only TST +T-SPOT.TB | € 673,245 € 387,135 € 342,563 |
Fox et al. [16] | Not assessed | Israel | 100 HCWs | Costs for screening and treatment | TST-only QFT-only TST+QFT | € 8,127 € 7,280 € 4,827 |
Diel et al. [17] | 2 years | Germany | Close contacts | Costs | TST-only QFT-only TST+QFT TST+QFT in BCG-vaccinated | € 91.06 € 61.29 € 52.05 € 55.45 |
Hardy et al. [18] | Not assessed | UK | Immigrants | Total costs/LTBI identified | QFT-only TST+QFT | ₤ 93.16 ₤ 160.81 |
Diel et al. [19] | 2 years | Germany | Close contacts | Costs | TST QFT TST+QFT | € 232.58 € 215.79 € 227.89 |